Cronos Group Inc. (NASDAQ:CRON) currently has a daily average trading volume of 4.73M but it saw 1847805 shares traded on Thursday. With a market cap of 1.90B USD, the company’s enterprise value now stands nearly at $565.30M. Stock’s current market price of $5.42 came rising about 1.12 while comparing to the previous closing price of $5.36. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.41 and as low as $4.00. In the recent trading on the day, stock has struck highest price mark of $5.46 while lowest mark touched by it was $5.32.

Taking a look at 20-day trading activity of Cronos Group Inc. (CRON) gives us an average price of $5.82, while its current price level is -56.33% below from 52-week high level whereas it is 35.50% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $6.20 while that of 200 days or SMA-200 reads an average of $6.43. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.33% during that period while stretching the period over a month that increases to 4.69%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 40.50 which implies that the stock is in neutral territory.

Cronos Group Inc. (CRON)’s stock is currently under the radar of 13 analysts who are in consensus at a 12-month price target range of between $4.18 and $8.30 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $4.18 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $8.30. Average price target assigned by them is $6.17 which highlights an upside potential of 12.16% for the stock over that period. And to attain the median price target of $6.03 assigned by those analysts, stock has to add about 10.12% of value to its current levels.

Data by FactSet Research shows that 13 analysts have issued their ratings for the stock. 2 of them are in opinions that stock is a Sell, while 1 are advising it as an Overweight. 2 analysts suggested the investors to Buy the stock while 8 advised them to Hold.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Raymond James which upgraded the stock as “Outperform” in its note to investors issued on June 24, 2020, recommending a price target of for it. Raymond James downgraded its recommendation for the stock as a “Mkt Perform” from “Outperform” on April 27, 2020 while assigning a price target of . Piper Sandler issued its recommendations for the stock as it downgraded the price target for the stock is .

Over the week, CRON’s stock price is moving 0.18% up while it is -19.70% when we observe its performance for the past one month. Year-to-date it is -29.34% down and over the past year, the stock is showing a downside performance of -51.35%.

Currently, Cronos Group Inc.’s total number of outstanding shares is 349.89M with 45.43% of that held by the insiders while 17.50% of its common stock has been owned by the institutions. It has a price to earnings ratio (P/E ratio) of 2.78. Stock has a price to book (P/B) ratio of 1.14 while price to sale or P/S ratio amounts to 60.38.

A filing at the U.S. Securities and Exchange Commission revealed that ETFMG Alternative Harvest ETF came shrinking its share ownership by 0.23% in the Cronos Group Inc. (CRON) increasing its stake to 2.36% with control over 18542.0 shares in the company. As per SEC documents, ETFMG Alternative Harvest ETF shunned 8,237,865 of company’s common stock of worth $53.96 million as per recent closing price of the stock. ETFMG Alternative Harvest ETF is not the only institutional holder which restructured its stake in Cronos Group Inc., as Horizons Medical Marijuana Life S dumped 5,088,958 shares of worth $33.33 million to bring its holdings to a total of 0.0 shares. In the most recent quarter, Vanguard Total International Stoc came cutting its stake by -1.66% in the company and now holds 3.08 million or 0.88% of the company’s stake having worth of about 20.19 million.